China Pharma Coverage Initiated by Analysts at StockNews.com
CPHI Stock | USD 0.22 0.02 8.33% |
Under 62% of China Pharma's investor base is looking to short. The analysis of overall sentiment of trading China Pharma Holdings stock suggests that many investors are alarmed at this time. China Pharma's investing sentiment shows overall attitude of investors towards China Pharma Holdings.
China |
StockNews.com started coverage on shares of China Pharma in a research note issued to investors on Friday morning. The brokerage issued a hold rating on the stock. China Pharma Trading Down 3.4 percent Shares of CPHI stock opened at 0.19 on Friday. The company has a quick ratio of 0.26, a
Read at thelincolnianonline.com
China Pharma Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards China Pharma can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
China Pharma Fundamental Analysis
We analyze China Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of China Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of China Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Shares Shorted
Number Of Shares Shorted Comparative Analysis
China Pharma is currently under evaluation in number of shares shorted category among its peers. Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
China Pharma Holdings Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with China Pharma stock to make a market-neutral strategy. Peer analysis of China Pharma could also be used in its relative valuation, which is a method of valuing China Pharma by comparing valuation metrics with similar companies.
Peers
China Pharma Related Equities
BFRI | Biofrontera | 6.60 | ||||
UPC | Universe Pharmaceuticals | 2.38 | ||||
PTPI | Petros Pharmaceuticals | 3.45 | ||||
LFCR | Lifecore Biomedical | 3.70 | ||||
SNOA | Sonoma Pharmaceuticals | 4.09 | ||||
SHPH | Shuttle Pharmaceuticals | 5.06 | ||||
AKAN | Akanda Corp | 8.07 | ||||
SXTC | China SXT | 8.89 |
Complementary Tools for China Stock analysis
When running China Pharma's price analysis, check to measure China Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy China Pharma is operating at the current time. Most of China Pharma's value examination focuses on studying past and present price action to predict the probability of China Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move China Pharma's price. Additionally, you may evaluate how the addition of China Pharma to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |